Survival increases in infantile acute lymphoblastic leukemia
Keywords:
precursor cell lymphoblastic leukemia-lymphomaAbstract
Acute lymphoblastic leukaemia represents 80% of all the cases of infantile leukaemias and it is one of the first malignant disease in those that therapeutic clinical studies have been made to great scale. With the improvement of the therapeutic outlines the prognosis of the children with acute lymphoblastic leukaemia has improved considerably in the last four decades, with rates of survival to the five years higher than 80%. The achievements in the “José Luis Miranda” Pediatric Hospital in Villa Clara is located at the level of national and internationally informed, with 84% of survival at five years and 16.5% of relapses; they are also informed late adverse effects.Downloads
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).